155 related articles for article (PubMed ID: 3679189)
1. Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody.
Weiss LM; Strickler JG; Medeiros LJ; Gerdes J; Stein H; Warnke RA
Hum Pathol; 1987 Nov; 18(11):1155-9. PubMed ID: 3679189
[TBL] [Abstract][Full Text] [Related]
2. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
3. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
4. Dendritic reticulum cells and immunophenotype in aspiration biopsies of lymph nodes. Value in the subclassification of non-Hodgkin's lymphomas.
Kornstein MJ; Wakely PE; Kardos TF; Frable WJ
Am J Clin Pathol; 1990 Aug; 94(2):165-9. PubMed ID: 2196777
[TBL] [Abstract][Full Text] [Related]
5. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
[TBL] [Abstract][Full Text] [Related]
6. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
7. Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas.
Sviatoha V; Tani E; Rassidakis G; Tribukait B; Kleina R; Skoog L
Cytopathology; 2000 Oct; 11(5):290-301. PubMed ID: 11014656
[TBL] [Abstract][Full Text] [Related]
8. [Mitotic regimen of non-Hodgkin's lymphoma].
Dubrovskiĭ ACh; Kliukina LB
Klin Lab Diagn; 1995; (5):8-11. PubMed ID: 7582784
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
Weisenburger DD
Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
[TBL] [Abstract][Full Text] [Related]
10. Transferrin receptor expression by non-Hodgkin's lymphomas. Correlation with morphologic grade and survival.
Medeiros LJ; Picker LJ; Horning SJ; Warnke RA
Cancer; 1988 May; 61(9):1844-51. PubMed ID: 3355978
[TBL] [Abstract][Full Text] [Related]
11. Classification of 1,198 cases of bovine lymphoma using the National Cancer Institute Working Formulation for human non-Hodgkin's lymphomas.
Vernau W; Valli VE; Dukes TW; Jacobs RM; Shoukri M; Heeney JL
Vet Pathol; 1992 May; 29(3):183-95. PubMed ID: 1621329
[TBL] [Abstract][Full Text] [Related]
12. Proliferation in non-Hodgkin's lymphomas as determined by immunohistochemical double staining for Ki-67.
Tominaga K; Yamaguchi Y; Nozawa Y; Abe M; Wakasa H
Hematol Oncol; 1992; 10(3-4):163-9. PubMed ID: 1398512
[TBL] [Abstract][Full Text] [Related]
13. Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysis.
Leoncini L; Cossu A; Megha T; Bellan C; Lazzi S; Luzi P; Tosi P; Barbini P; Cevenini G; Pileri S; Giordano A; Kraft R; Laissue JA; Cottier H
Int J Cancer; 1999 Oct; 83(2):203-9. PubMed ID: 10471528
[TBL] [Abstract][Full Text] [Related]
14. Morphologic studies of lymphocyte nuclei in follicular and diffuse mixed small- and large-cell (lymphocytic-histiocytic) lymphoma.
Dardick I; Caldwell DR; Moher D; Jabi M
Hum Pathol; 1988 Aug; 19(8):889-901. PubMed ID: 3042597
[TBL] [Abstract][Full Text] [Related]
15. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
16. An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute.
Garvin AJ; Simon RM; Osborne CK; Merrill J; Young RC; Berard CW
Cancer; 1983 Aug; 52(3):393-8. PubMed ID: 6344979
[TBL] [Abstract][Full Text] [Related]
17. Expression of Tac antigen by non-Hodgkin's lymphomas.
Weiss LM; Michie SA; Medeiros LJ; Strickler JG; Garcia CF; Warnke RA
Am J Clin Pathol; 1987 Oct; 88(4):483-5. PubMed ID: 2821794
[TBL] [Abstract][Full Text] [Related]
18. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
[TBL] [Abstract][Full Text] [Related]
19. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
[TBL] [Abstract][Full Text] [Related]
20. Expression of the activation antigen, 4F2, by non-Hodgkin's lymphomas of B-cell phenotype.
Lewandrowski KB; Medeiros LJ; Harris NL
Cancer; 1990 Sep; 66(6):1158-64. PubMed ID: 1698116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
